- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 23.14M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 23.14M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 23.01M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | −$7.09M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$17.46M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $21.85M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $28.93M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $19.99M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $31.47M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $80.01M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $98.67M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $7.26M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $8.2M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $7.63M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $8.67M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $26.86M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $34.22M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $27.61M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $40.14M |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | −$0.51 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.85 |
| Eps Basic | Q1 2025 · Mar 31, 2025 | −$0.51 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.85 |
| Sga Expense | Q1 2025 · Mar 31, 2025 | $4.81M |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $4.9M |
| Rd Expense | Q1 2025 · Mar 31, 2025 | $4.36M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $15.79M |
| Net Income | Q1 2025 · Mar 31, 2025 | −$11.81M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$19.63M |
| Operating Income | Q1 2025 · Mar 31, 2025 | −$9.16M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$20.69M |
| Capex | Q1 2025 · Mar 31, 2024 | $144K |